Cargando…
A Network Pharmacology Study to Uncover the Multiple Molecular Mechanism of the Chinese Patent Medicine Toujiequwen Granules in the Treatment of Corona Virus Disease 2019 (COVID-19)
Since the outbreak of the novel corona virus disease 2019 (COVID-19) at the end of 2019, specific antiviral drugs have been lacking. A Chinese patent medicine Toujiequwen granules has been promoted in the treatment of COVID-19. The present study was designed to reveal the molecular mechanism of Touj...
Autores principales: | Yang, Bao-yu, Wang, Hao-zhen, Ma, Zhen-zhong, Lu, Chen, Li, Yang, Lu, Zi-yin, Lu, Xiu-li, Gao, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Huazhong University of Science and Technology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056192/ https://www.ncbi.nlm.nih.gov/pubmed/33877545 http://dx.doi.org/10.1007/s11596-021-2346-x |
Ejemplares similares
-
Jingtong Granule: A Chinese Patent Medicine for Cervical Radiculopathy
por: Zhu, Liguo, et al.
Publicado: (2015) -
Clinical efficacy of Jingyin granules, a Chinese patent medicine, in treating patients infected with coronavirus disease 2019
por: Chen, Bowu, et al.
Publicado: (2023) -
A Randomized Controlled Trial of Chinese Patent Medicine Xiao'er Biantong Granules in the Treatment of Functional Constipation in Children
por: Cai, Qiu-han, et al.
Publicado: (2018) -
Traditional Chinese Herbal Medication for corona-virus 2019
por: Hassan, Amir
Publicado: (2020) -
Corrigendum to “A Randomized Controlled Trial of Chinese Patent Medicine Xiao'er Biantong Granules in the Treatment of Functional Constipation in Children”
por: Cai, Qiu-han, et al.
Publicado: (2018)